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Excessive fructose consumption and elevated glucocorticoids contribute to metabolic syndrome. We
show that fructose as the only carbohydrate source is sufﬁcient for the differentiation of 3T3-L1
ﬁbroblasts into adipocytes. Differentiation of cells in fructose containing medium resulted in
increased 11b-hydroxysteroid dehydrogenase 1 (11b-HSD1) expression and activity. Experiments
with transfected HEK-293 cells suggested more efﬁcient NADPH generation by fructose compared
with glucose in the endoplasmic reticulum (ER). Adipocytes differentiated in the presence of
fructose showed increased FABP4 expression, C/EBPa to C/EBPb ratio and lipolysis. Thus, excessive
fructose may cause adverse metabolic effects by enhancing 11b-HSD1 activity and increasing lipol-
ysis in adipocytes.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Consumption of fructose has increased dramatically in the last
decades; the majority is taken up in the form of sucrose and
high-fructose corn syrup [1,2]. The signiﬁcant increase in fructose
intake has been associated with the development of obesity, insu-
lin resistance, dyslipidemia, type 2 diabetes, hypertension and
chronic kidney disease [3–6]. In humans, fructose is metabolized
primarily in the liver following absorption mainly in the jejunum;
however to a lesser extent it is utilized in peripheral tissues [7]. In
the liver, fructose is metabolized by fructokinase to fructose-1-
phosphate, which subsequently in the form of triose phosphates
can enter glycolysis, lipid synthesis, gluconeogenesis and/or glyco-
genesis pathways [7]. In contrast, fructokinase is not expressed inadipose tissue and fructose is metabolized by hexokinase to fruc-
tose-6-phosphate (F6P) [8].
We recently provided evidence that F6P is transported into the
endoplasmic reticulum (ER) and can serve as a source for luminal
generation of NADPH involving a luminal hexose-6-phosphate isom-
erase and hexose-6-phosphate dehydrogenase (H6PDH) [9]. The re-
dox state of nicotinamide adenine dinucleotide phosphate in the ER
lumen is dependent onH6PDH and determines the intracellular acti-
vation of glucocorticoids mediated by 11b-hydroxysteroid dehydro-
genase 1 (11b-HSD1) [10–12]. Importantly, overexpression of
11b-HSD1 speciﬁcally in adipose tissue caused metabolic syndrome
inmice [13]. Glucocorticoids are known to promote adipocyte differ-
entiation and they contribute to dyslipidemia and visceral fat accu-
mulation [14,15]. Besides their adipogenic effects, glucocorticoids
inﬂuence the availability of free fatty acids (FFA) by directly stimu-
lating lipolysis in a dose- and time-responsive manner as shown in
experiments using rat primary adipocytes and mouse 3T3-L1 adipo-
cytes [16–18]. Together, these results suggested that elevated intra-
cellular activation of glucocorticoids stimulates the differentiation of
preadipocytes to adipocytes and enhances the expression of lipolytic
lipases, thereby increasing the production of glycerol and the release
of FFA.
Peroxisome proliferator-activated receptor c (PPARc), and
CCAT/enhancer-binding protein a (C/EBPa) are transcription fac-
tors known to regulate the differentiation of preadipocytes into
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play an important role in the regulation of 11b-HSD1 expression
and therefore in the local availability of active glucocorticoids
[21–24]. We have shown earlier that C/EBPa is a more potent acti-
vator of 11b-HSD1 expression than C/EBPb and that an elevated ra-
tio of C/EBPa to C/EBPb is associated with enhanced 11b-HSD1
expression [25].
Nevertheless, the impact of fructose on adipogenesis and its ef-
fect on the regulation of 11b-HSD1 expression and activity are not
fully understood. In the present study, we used the mouse 3T3-L1
cell model to investigate how fructose affects the differentiation of
the 3T3-L1 ﬁbroblasts into mature adipocytes. Our results provide
evidence for a more pronounced adipocyte differentiation when
fructose instead of glucose is used in the differentiation medium.
Furthermore, the results support our hypothesis that fructose aug-
ments 11b-HSD1-dependent glucocorticoid activation and in-
creases the expression and activities of hormone sensitive lipase
(HSL) and adipocyte triglyceride lipase (ATGL), thereby accelerat-
ing lipid metabolism in adipocytes.
2. Materials and methods
2.1. Materials
Cell culture media, oligo-dT and Superscript II reverse transcrip-
tase were purchased from Invitrogen (Carlsbad, CA), [1,2,6,7-3H]-
cortisone from Amersham Pharmacia, Dübendorf, Switzerland,
and SIL G-25 UV254 thin layer chromatography (TLC) plates from
Macherey-Nagel, Oensingen, Switzerland. All other chemicals were
from Fluka AG, Buchs, Switzerland, and were of the highest grade
available.
2.2. Cultivation of 3T3-L1 cells and differentiation into adipocytes
Murine 3T3-L1 cells, obtained from American Type Culture Col-
lection (ATCC, Manassas, VA), were cultured in Dulbecco’s modiﬁed
Eagles medium (DMEM) supplemented with 10% fetal bovine ser-
um (FBS) under non-differentiating and differentiating conditions
in a humidiﬁed incubator at 5% CO2 and 37 C as described
previously [26]. Brieﬂy, 2 days after reaching conﬂuence (desig-
nated as day 0 of differentiation) preadipocytes were subjected
to differentiation medium (DMEM, 10% FBS, 0.25 mM 3-isobu-
thyl-1-methylxanthine, 0.5 lM dexamethasone, 1 lg/ml insulin)
for further 2 days. The medium was then replaced with adipocyte
growth medium (DMEM, 10% FBS, 1 lg/ml insulin) (day 2) and
3 days later (day 5) with DMEM and 10% FBS but in the absence
of insulin.
2.3. RNA isolation and analysis
Total RNA was extracted from adherent cultured 3T3-L1 cells
using Trizol reagent, followed by reverse transcription using Super-
script II reverse transcriptase (Invitrogen) as described previously
[21]. The mRNA levels from different genes were analyzed using a
Rotor-Gene 6000 light cycler (Corbett, Sydney, Australia). Brieﬂy,
reactions were performed in a total volume of 10 ll reaction buffer
containing TaqMan Universal PCR Master Mix (Life Technologies,
Zug, Switzerland) or KAPA SYBR master mix (Kapasystems, Boston,
MA), 20 ng cDNA and speciﬁc oligonucleotide primers and se-
quence probes for each gene from Assay on Demand (Invitrogen).
The data from the analysis of the relative expression of each gene
versus the internal control hypoxanthine-guanine phosphoribosyl-
transferase (HPRT) control probe were determined using the
2DDCTmethod [27]. Critical threshold (CT) valueswere determined
from at least three independent experiments, each measured in
triplicate.2.4. Immunoblot analysis
Cells were washed with PBS and harvested in RIPA buffer con-
taining proteinase inhibitor cocktail (Roche Diagnostics, Rotkreuz,
Switzerland). Lysates were cleared by centrifugation and total pro-
tein concentration was determined using the BCA Protein Assay Kit
(Thermo Scientiﬁc, Wohlen, Switzerland) Equivalent amounts of
protein (30 lg) were separated by 8% SDS–PAGE and subsequently
electrotransferred to polyvinylidene diﬂuoride membranes (Hy-
bond-P, Amersham-Pharmacia Biotech, Piscataway, NJ), followed
by incubation with antibodies against perilipin, HSL, HSL phos-
phorylated on Ser563 and on Ser660 (Lipolysis Antibody Samples
Kit, Cell Signaling Technology, Beverly, MA), and b-actin (Santa
Cruz Biotechnology, Santa Cruz, CA) as a loading control. Proteins
were detected using horseradish peroxidase-conjugated secondary
antibodies (Santa Cruz Biotechnology).
2.5. Oil Red-O staining
For Oil Red-O staining, 3T3-L1 cells were ﬁxed with 4% formal-
dehyde in PBS for 10 min. washed with PBS and dried. After ﬁxa-
tion cells were stained with Oil Red-O staining solution for
20 min at room temperature, followed by thrice washing with
PBS. To quantify intracellular lipid content, total lipids were ex-
tracted with isopropyl alcohol and the extracted solution was mea-
sured using a colorimeter at 540 nm.
2.6. Lipolysis assay
Lipolytic activity was detected by measuring both free glycerol
and free non-esteriﬁed fatty acids (FFA) released into the medium,
according to the manufacturer’s protocol (Zen-Bio, Inc., Research
Triangle Park, NC). Partially (day 4) and fully differentiated adipo-
cytes (day 8) were rinsed twice with Washing Buffer. After wash-
ing, cells were incubated in Assay Buffer for 3 h at 37 C. The
released free glycerol and FFA were detected by comparing the
concentrations in the respective medium with a calibration curve.
The optical density of each well (using triplicates in each individual
experiment) was measured at 540 nm using a spectrophotometer
plate reader.
2.7. Determination of 11b-HSD1 activity
The oxoreductase activity of 11b-HSD1 was determined in 3T3-
L1 and HEK-293 cells by measuring the conversion of cortisone to
cortisol in intact cells as described previously [28,29]. Brieﬂy, radi-
olabeled cortisone was added to intact HEK-293 cells or intact
undifferentiated and differentiated 3T3-L1 cells at a ﬁnal concen-
tration of 200 nM, followed by incubated for up to 6 h at 37 C. Ste-
roids were extracted from the mediumwith ethyl acetate, followed
by separation by TLC using a solvent system of 9:1 (v/v) chloro-
form:methanol. The bands corresponding to cortisone and cortisol
were excised and analyzed by scintillation counting.3. Results
3.1. Fructose promotes adipocyte differentiation
Because excessive fructose consumption has been associated
with metabolic disease [5] and overexpression of 11b-HSD1 has
been shown to cause metabolic syndrome in mice [13], we inves-
tigated whether fructose would stimulate 11b-HSD1 expression
and activity in 3T3-L1 adipocytes and whether 3T3-L1 ﬁbroblasts
are capable of undergoing differentiation into adipocytes in the
presence of fructose as the only carbohydrate source. We observed
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medium containing glucose or fructose (Fig. 1A). The formation
of lipid droplets occurred similarly in fructose and glucose
containing medium as determined by light microscopy. Unexpect-
edly, Oil Red-O staining revealed higher total lipid content in cells
incubated with fructose on day 4 and day 8 of differentiation
(Fig. 1B). Furthermore, we measured the expression of the genes
encoding the adipocyte-speciﬁc proteins FABP4, PPARc and 11b-
HSD1 at different time points of differentiation. About two-fold
higher expression of FABP4 and PPARc mRNA was observed after
4, 6 and 8 days of differentiation in fructose compared with glucose
containing medium (Fig. 1C). In contrast, there was no signiﬁcant
change in the mRNA expression of PPARc and 11b-HSD1.
Because we previously found that C/EBPa is a more potent acti-
vator of 11b-HSD1 expression than C/EBPb, we measured the
mRNA expression of these transcription factors (Fig. 1D). The most
remarkable difference was observed in the gene expression ratio of
C/EBPa to C/EBPb between fructose and glucose treated cells. InFig. 1. Fructose promotes adipocyte differentiation and increases the ratio of C/EBPa to C
two-day post-conﬂuence and were then subjected to differentiation medium containin
analyzed by light microscopy (A). The intracellular lipid content was quantitated by Oil R
11b-HSD1 mRNA levels was determined by quantitative RT-PCR and data were normalize
set as 1 (C). Expression of C/EBPa and C/EBPbmRNA levels was determined by quantitativ
the value for glucose at day 2 was set as 1 (D). The mRNA expression ratio of C/EBPa to C/E
or fructose (left) (E). Data represent mean ± S.D. from three independent experiments.glucose containing medium the ratio of C/EBPa to C/EBPb was
slightly elevated after 4 days of differentiation but not thereafter,
in contrast to fructose containing medium where it was three- to
four-fold elevated after 4, 6 and 8 days (Fig. 1E). The increased ratio
was due to a slight increase in C/EBPa and a decrease in C/EBPb
mRNA in fructose treated cells. Interestingly, when fully differenti-
ated 3T3-L1 adipocytes were incubated for 24 h in carbohydrate-
free medium or in medium containing 0.3 g/l glucose, the C/EBPa
to C/EBPb mRNA expression ratio decreased by 70%, whereas the
ratio was unaffected if cells were incubated in the presence of
0.3 g/l fructose (data not shown).
3.2. The inﬂuence of fructose on 11b-HSD1-mediated glucocorticoid
activation
Next, we tested the inﬂuence of fructose on 11b-HSD1 activity
in 3T3-L1 adipocytes at different time points of differentiation.
The pattern of 11b-HSD1 oxoreductase activity closely followed/EBPbmRNA expression in 3T3-L1 cells. Murine 3T3-L1 cells were allowed to achieve
g glucose or fructose as the only carbohydrate source. At day 8, morphology was
ed-O staining at days 4 and 8 of differentiation (B). Expression of FABP4, PPARc and
d to HPRT house-keeping control mRNA, whereby the value for glucose at day 2 was
e RT-PCR and data were normalized to HPRT house-keeping control mRNA, whereby
BPbwas measured at different time of incubation in medium contain glucose (right)
Fig. 3. The inﬂuence of fructose and glucose on GLUT5 mRNA expression during
adipocyte differentiation. Murine 3T3-L1 cells were differentiated in medium with
glucose or fructose as the only carbohydrate source. Expression of GLUT5 mRNA
levels was determined by quantitative PCR and normalized to HPRT mRNA at the
different days indicated in medium contain glucose or fructose. The values at day 2
were set as 1. Data represent mean ± S.D. from three independent experiments.
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differentiation. Interestingly, a signiﬁcantly higher 11b-HSD1 oxo-
reductase activity was observed in adipocytes differentiated in the
presence of fructose (Fig. 2A). Thus, fructose as the only carbohy-
drate source was sufﬁcient to induce 11b-HSD1 expression and
activity in adipocytes, and the activity obtained was slightly higher
than that of adipocytes cultivated in the presence of glucose.
11b-HSD1 is a reversible enzyme that is dependent on the avail-
ability of NADPH in the endoplasmic reticulum [10,30]. Therefore,
we aimed to determine the direct impact of the carbohydrate
source on the ability of 11b-HSD1 to regenerate active glucocorti-
coids, independent of gene expression. We measured the amount
of cortisol formed from cortisone and the amount of cortisone
formed from cortisol, respectively, in HEK-293 cells stably express-
ing 11b-HSD1 and H6PDH (clone HHH7) under steady state condi-
tions after incubation for 24 h in medium containing glucose or
fructose. The ratios of active to inactive glucocorticoids observed
at 4.5 g/l glucose and fructose, respectively, were comparable
(Fig. 2B and C). However, at carbohydrate concentrations of 0.1
and 1 g/l, fructose was clearly more efﬁcient than glucose in stim-
ulating 11b-HSD1 oxoreductase activity and resulting in higher
levels of active glucocorticoids, suggesting that luminal NADPH
generation occurs more efﬁciently in the presence of fructose.3.3. Fructose leads to higher glucose transporter 5 (GLUT5) expression
in 3T3-L1 adipocytes than glucose
Since GLUT5 (SLC2A5) is the main fructose transporter ex-
pressed in enterocytes in the small intestine, skeletal muscle, tes-
tis, kidney, fat tissue and brain [31], we determined the GLUT5
gene expression levels in 3T3-L1 cells during differentiation and
tested whether the fructose transporter is present in HEK-293
cells. We found that GLUT5 is well expressed in 3T3-L1 preadipo-
cytes and that its level decreased by about 50% during the differen-
tiation to mature adipocytes when the cells were cultured in the
presence of glucose (Fig. 3), in line with an earlier study [32]. In
contrast, GLUT5 mRNA levels were comparable at days 2 and 8,
and they even were slightly higher at days 4 and 6 when the cells
were cultivated in the presence of fructose. In addition, we veriﬁed
the expression of GLUT5 in HEK-293 cells, providing an explana-
tion for our observation that these cells can be cultivated in med-
ium containing fructose as the only carbohydrate source (data not
shown).Fig. 2. The inﬂuence of fructose on the interconversion of glucocorticoids in 3T3-L1 cell
3T3-L1 cells at days 3, 6, and 9, and enzyme activity was measured by incubation of cells
and H6PDH were incubated in the absence of carbohydrates or in the presence of the fruc
for further 24 h with either 200 nM cortisone (B) or 200 nM cortisol (C) and determin
mean ± S.D. from three independent experiments performed in triplicate. ⁄P < 0.05, ⁄⁄P <3.4. Fructose accelerates lipid metabolism
Both C/EBPs and glucocorticoids have been shown to induce the
expression of genes involved in the differentiation of adipocytes
and to alter lipid metabolism; therefore we investigated the inﬂu-
ence of fructose containing medium on the expression of lipolytic
genes during differentiation of 3T3-L1 cells. The expression of HSL
and ATGL mRNA levels were signiﬁcantly higher in fructose com-
pared with glucose containing medium, respectively, after 6 days
of differentiation (Fig. 4A). Importantly, using a lipolysis activation
antibody kit to detect perilipin as well as HSL and its Ser563 and
Ser660 phosphorylated forms suggested accelerated lipolysis when
cells were differentiated in the presence of fructose (Fig. 4B). The
protein expression of perilipin as well as that of HSL and its phos-
phorylated forms was increased at day 4 and day 8 of differentia-
tion in fructose treated cells. In line with these results, the
release of glycerol and FFA into the medium was signiﬁcantly ele-
vated in fructose compared with glucose treated cells, as detected
by a lipolysis assay kit (Fig. 4C).
4. Discussion
Excessive fructose consumption has been associated with the
development of obesity and metabolic diseases [2,4,33,34].s. The 11b-HSD1-dependent oxoreduction of cortisone to cortisol was measured in
with 200 nM cortisone for up to 6 h (A). HEK-293 cells stably expressing 11b-HSD1
tose or glucose concentration indicated for 24 h, followed by incubation of the cells
ation of the formation of cortisol (B) or cortisone (C), respectively. Data represent
0.01, ⁄⁄⁄P < 0.001.
Fig. 4. Enhanced lipolysis in 3T3-L1 cells differentiated in fructose compared with glucose containing medium. Murine 3T3-L1 cells were differentiated in medium with
glucose or fructose as the only carbohydrate source. Expression of HSL and ATGL mRNA levels at the different days indicated was determined by quantitative PCR and
normalized to HPRT mRNA, whereby the value from glucose treated cells was set as 1 (A). The protein expression of perilipin, HSL and its phosphorylated forms (Ser 563 and
Ser 660) was analyzed at day 4 and day 8 of differentiation by Western blotting using a lipolysis activation antibody kit (B). Protein levels were normalized to b-actin control.
The release of glycerol and free fatty acids (FFA) into the medium of glucose and fructose treated cells was detected using a lipolysis assay kit (C). ⁄P < 0.05, ⁄⁄P < 0.01,
⁄⁄⁄P < 0.001.
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glucose sweetened beverages caused an increase in visceral adi-
posity and a decrease in insulin sensitivity in overweight and obese
individuals [34], the mechanisms underlying the effects of fructose
on adipogenesis and lipid metabolism are not fully understood.
Upon ingestion of fructose, approximately 50–60% is metabolized
in the liver, 20% in the kidneys and the remainder reaches periph-
eral tissues such as the adipose [7,31]. Adipocytes express GLUT5
and are therefore able to efﬁciently take up fructose [35]. Evidence
from early studies on adipocytes indicated that at high concentra-
tions, i.e. 1 and 4.5 g/l, the transport of fructose can far exceed that
of glucose, while at low, more physiologically relevant concentra-
tions, i.e. 0.1 g/l, the uptake of glucose is more efﬁcient than that
of fructose [36]. The ﬁnding of the present study that GLUT5 gene
expression was higher in 3T3-L1 adipocytes cultivated in the pres-
ence of fructose compared with glucose suggests that fructosestimulates its own uptake, which may be needed for efﬁcient up-
take at low concentrations.
In adipocytes, hexokinase is thought to be the major enzyme
responsible for fructose metabolism, thereby generating F6P [7].
F6P can be converted to G6P by glucose-6-phosphate isomerase
in the cytoplasm. Alternatively, we recently provided evidence
for F6P transport into the ER and characterized an ER luminal hex-
ose-6-phosphate isomerase that converts F6P to G6P [9]. It is not
clear at present whether the ER luminal G6P is provided by the
cytoplasmic G6P pool via the glucose-6-phosphate transporter or
whether it is formed from F6P by the luminal isomerase. To clarify
this, further research on the uptake and metabolism of fructose
and glucose is needed. Nevertheless, G6P is required as a substrate
for H6PDH to generate luminal NADPH, and regeneration of
NADPH stimulates the local activation of glucocorticoids by
11b-HSD1 [30]. In the present study, we observed higher
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fructose containing medium. Also, a signiﬁcantly higher ratio of ac-
tive to inactive glucocorticoids after reaching steady-state was de-
tected in HEK-293 cells stably expressing 11b-HSD1 and H6PDH
upon incubation in fructose compared with glucose containing
medium. These results suggest that fructose is superior to glucose
in supplying substrate for H6PDH to generate NADPH within the
ER and to subsequently form active glucocorticoids. The elevated
glucocorticoids may further stimulate cellular fructose uptake by
upregulation of GLUT5. GLUT5 expression was found to be induced
by fructose in the intestine, and the fructose-mediated stimulation
was further enhanced by glucocorticoids [37]. In addition, in an
analysis of the GLUT5 promoter, we found several putative gluco-
corticoid receptor response elements (data not shown).
Maintenance of the pool of reduced luminal pyridine nucleo-
tides within the ER seems to be important in the process of adipo-
genesis, since it was shown that depletion of luminal NADPH
disrupted preadipocyte differentiation [38]. It has been shown pre-
viously that fructose stimulates adipogenesis [32]. The results of
the present study showed that fructose is superior to glucose in
inducing adipocyte markers and increasing 11b-HSD1 activity.
Fructose can be efﬁciently utilized by 3T3-L1 adipocytes and, as
the only carbohydrate source, is sufﬁcient for the induction of adi-
pogenic gene expression and the terminal differentiation of adipo-
cytes. 3T3-L1 preadipocytes were allowed to achieve two-day
post-conﬂuence. This growth-arrest is necessary for preadipocyte
differentiation [39], where cells receive adipogenic and mitogenic
signals and subsequently undergo terminal differentiation. Several
studies showed that expression of C/EBPb is a prerequisite for
mitotic clonal expansion, which is necessary for terminal differen-
tiation into mature adipocytes [40–42]. C/EBPb is an early regula-
tor of preadipocyte differentiation that induces the expression of
C/EBPa. When the cells complete clonal expansion and subse-
quently enter terminal differentiation, the expression of C/EBPa
and PPARcmaintain the differentiation process. C/EBPa and PPARc
act synergistically to activate the transcription of genes responsible
for the adipocyte phenotype [43].
In the present study, we observed an increased ratio of C/EBPa
to C/EBPb in adipocytes differentiated in fructose containing med-
ium compared with cells that were cultivated in the presence of
glucose. An elevated ratio of C/EBPa to C/EBPb has been associated
with increased expression of 11b-HSD1 and decreased expression
of 11b-HSD2 in previous studies [21,25]. Using promoter con-
structs of human HSD11B1 and HSD11B2, a differential regulation
of these two genes was observed, whereby an elevated ratio of C/
EBPa to C/EBPb expression has been associated with elevated lev-
els of active glucocorticoids. Thus, the elevated 11b-HSD1 expres-
sion detected in fructose treated 3T3-L1 adipocytes may be
explained by the increased ratio of C/EBPa to C/EBPb expression.
The fructose mediated elevation of the concentration of active
glucocorticoids is likely to further promote adipogenesis and lipol-
ysis. It has been shown that glucocorticoids stimulate the expres-
sion of adipogenic genes and of lipolysis by down-regulating
cyclic-nucleotide phosphodiesterase 3B, which results in a subse-
quent elevation of cellular cAMP production and activation of
PKA [18]. After the commitment to adipose lineage, growth-
arrested preadipocytes differentiate to adipocytes in the presence
of glucocorticoids and/or mediators increasing cAMP levels
[44,45]. Elevated cAMP levels have been suggested to transcrip-
tionally activate C/EBPb by cAMP response element binding pro-
tein (CREB) [46] and/or post-translational modiﬁcation via
phosphorylation [47], which leads to enhanced DNA-binding. The
elevated expression ratio of C/EBPa to C/EBPb observed in the pres-
ent work suggests that fructose promotes the maintenance of the
adipocyte phenotype. The activation of PKA in the presence of in-
creased glucocorticoids was shown to activate lipolysis byphosphorylation of perilipin and an induction of lipases such as
HSL and ATGL, thus resulting in an increased production of glycerol
and FFA. Thus, the elevated lipolysis found in the present study
upon differentiation of 3T3-L1 adipocytes in medium where glu-
cose was replaced by fructose as the carbohydrate source may be
at least in part due to elevated 11b-HSD1 activity.
In conclusion, our results suggest that fructose is a potent adi-
pocyte differentiation agent by stimulating NADPH generation in
the ER and subsequent activation of glucocorticoids. High fructose
levels accelerated lipid metabolism by increasing HSL and ATGL li-
pase activity, probably stimulated by the increased activation of
glucocorticoids. Fructose was found to be superior to glucose in
promoting the differentiation of 3T3-L1 adipocytes and in enhanc-
ing 11b-HSD1 expression and activity as well as increasing
lipolysis.
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